DUGRESSA 1 mg/ml + 5 mg/ml, eye drop solution bottle, 5 ml
Active ingredients: Dexamethasone, Levofloxacin, Levofloxacin hemihydrate, Dexamethasone sodium phosphate
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solutionbottle, 5 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DUGRESSA 1 mg/mL + 5 mg/mL, collyre en solution
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon(s) polyéthylène basse densité (PEBD) avec compte-gouttes de 5 ml
- Marketing authorisation holder
- SANTEN OY
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 14 Feb 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65463715CIP73021053CIP133400930210536Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DEXAMÉTHASONEcollyre | 1 mg · 1 mL de collyre en solution | FT |
| PHOSPHATE SODIQUE DE DEXAMÉTHASONEcollyre | — | SA |
| LÉVOFLOXACINE HÉMIHYDRATÉEcollyre | — | SA |
| LÉVOFLOXACINEcollyre | 5 mg · 1 mL de collyre en solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.